Detalhe da pesquisa
1.
Prediction of whole-cell transcriptional response with machine learning.
Bioinformatics
; 38(2): 404-409, 2022 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570169
2.
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.
Proc Natl Acad Sci U S A
; 117(22): 12315-12323, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424106
3.
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.
Proc Natl Acad Sci U S A
; 115(18): E4179-E4188, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29581250
4.
Robustness and reproducibility of simple and complex synthetic logic circuit designs using a DBTL loop.
Synth Biol (Oxf)
; 8(1): ysad005, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37073283
5.
A toolkit for enhanced reproducibility of RNASeq analysis for synthetic biologists.
Synth Biol (Oxf)
; 7(1): ysac012, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36035514
6.
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.
Clin Cancer Res
; 27(17): 4923-4936, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145028
7.
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4.
Neoplasia
; 22(6): 253-262, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32403054
8.
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 26(17): 4616-4624, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727885
9.
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.
Oncogene
; 38(28): 5658-5669, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996246
10.
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.
Sci Rep
; 9(1): 3823, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846826
11.
Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer.
Oncotarget
; 8(67): 111084-111095, 2017 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29340039
12.
Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor.
Oncotarget
; 7(26): 40690-40703, 2016 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27276681
13.
Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer.
JAMA Oncol
; 5(4): 478-479, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30589921